Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by CytochromePon Oct 13, 2017 11:44am
77 Views
Post# 26809993

RE:RE:RE:RE:RE:RE:RE:RE:HOLDING APH FOR A LONG TIME

RE:RE:RE:RE:RE:RE:RE:RE:HOLDING APH FOR A LONG TIMEAsk your bay street friend what a 'risk-free rate of return' is, then ask him why his calculations are so heavily based on a false set of assumptions. I'm guessing he tried to apply some of them to this industry using traditional comparative formula with inappropriate controls as the comparatives.

The similarities between financial analysis and scientific research is mind-blowing, you can use the same critical eye when evaluating publications from both fields.

tjw4 wrote:
I agree with this and I think Im realistic when I think we can get half of Molsons market cap in the 7-8billion area which would put this stock at 50+ (assuming ZERO dilution which we all know is not realistic so Id expect more of a 25-35 price in a few years). 

FWIW my friends who work in major funds on bay street warned me to get out of the entire industry a couple months ago said the valuations are ridiculous and im crazy to be in it. I told them APH is different I do feel with this new EPS of 44c (assumption) we should at minimum double before July 1st, 18.



Bullboard Posts